Advertisement

Reactions Weekly

, Volume 1710, Issue 1, pp 65–65 | Cite as

Bevacizumab/paclitaxel

Fistula, intestinal perforation and sepsis: 5 case reports
Case report
  • 21 Downloads

Reference

  1. Godoy-Ortiz A, et al. Bevacizumab for recurrent, persistent or advanced cervical cancer: reproducibility of GOG 240 study results in "real world" patients. Clinical and Translational Oncology 20: 922-927, No. 7, Jul 2018. Available from: URL: http://doi.org/10.1007/s12094-017-1808-x - Spain

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations